Lupin, a global pharmaceutical leader, has been recognized for its exceptional sustainability efforts, receiving the highest “A” leadership rating from the Climate Disclosure Project (CDP) for both Climate Change and Water Security. This prestigious recognition solidifies Lupin’s position among the world’s most sustainable and transparent companies. The double “A” rating reflects Lupin’s significant progress in mitigating climate risks, reducing carbon emissions, and ensuring responsible water management across its operations.

Compared to its previous ratings, Lupin has made substantial improvements, upgrading from “A-” in 2024 and “B” and “C” in 2023 for climate and water, respectively. This remarkable achievement demonstrates Lupin’s commitment to sustainability and its proactive initiatives to minimize its environmental impact. Ramesh Swaminathan, Executive Director and Global CFO, expressed pride in earning the double “A” rating, attributing it to the company’s innovative approaches, collaborative efforts, and transparent practices.

Lupin’s sustainability endeavors have also been recognized by S&P Global, which awarded the company an ESG score of 91 in 2025. This achievement places Lupin among an elite group of companies worldwide that have surpassed the 90-point threshold, demonstrating its best-in-class sustainability performance. The CDP’s strict framework has played a significant role in shaping and accelerating Lupin’s climate initiatives, driving ongoing progress and commitment to establishing new sustainability standards.

The recognition from CDP and S&P Global underscores Lupin’s dedication to generating lasting value for its communities and the planet. As a global pharma leader, Lupin is committed to reducing its environmental impact through innovation, collaboration, and transparency, setting a high standard for sustainability in the industry. With its exceptional achievements, Lupin continues to demonstrate its position as a responsible and sustainable business leader, driving positive change and promoting a more environmentally conscious future.

Lupin, a global pharmaceutical company, has achieved a significant milestone in its sustainability journey by earning a double ‘A’ rating from CDP (formerly known as the Carbon Disclosure Project) for its leadership in climate action and water security. This prestigious rating recognizes Lupin’s efforts to reduce its environmental impact and mitigate the risks associated with climate change and water scarcity.

CDP is a non-profit organization that assesses companies’ environmental performance and transparency. The double ‘A’ rating is the highest rating given by CDP, and it indicates that Lupin has demonstrated exceptional leadership and commitment to environmental stewardship. Lupin is one of only a few companies globally to achieve this rating, and it is a testament to the company’s dedication to sustainability.

Lupin’s climate action efforts have focused on reducing greenhouse gas emissions, transitioning to renewable energy sources, and implementing energy-efficient technologies. The company has set ambitious targets to reduce its carbon footprint, including a goal to become carbon neutral by 2050. Lupin has also implemented various initiatives to promote sustainable practices throughout its supply chain, including working with suppliers to reduce their environmental impact.

In addition to its climate action efforts, Lupin has also demonstrated leadership in water security. The company has implemented water conservation measures across its operations, including rainwater harvesting and wastewater treatment. Lupin has also engaged with local communities to promote water conservation and support watershed development projects.

The double ‘A’ rating from CDP is a significant achievement for Lupin, and it reflects the company’s commitment to sustainability and environmental responsibility. Lupin’s leadership in climate action and water security will not only reduce its environmental impact but also contribute to the well-being of local communities and the planet as a whole. The company’s sustainability efforts are aligned with the United Nations’ Sustainable Development Goals (SDGs), and it is working to integrate the SDGs into its business strategy.

Overall, Lupin’s double ‘A’ rating from CDP is a testament to the company’s dedication to sustainability and environmental stewardship. The company’s efforts to reduce its environmental impact and promote sustainable practices will have a positive impact on the environment, local communities, and its business operations. As a responsible corporate citizen, Lupin is committed to continuing its sustainability journey and making a positive difference in the world.

Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest ‘A’ leadership rating from the Climate Disclosure Project (CDP) for its exceptional performance in Climate Change and Water Security. This recognition is a testament to Lupin’s commitment to sustainability and transparency, placing the company among the world’s leading organizations that prioritize environmental stewardship.

Lupin’s double ‘A’ rating in Climate and Water demonstrates its proactive approach to mitigating climate risks, reducing carbon emissions, and ensuring responsible water management throughout its operations. This achievement represents a significant improvement from the company’s previous ratings, with a substantial enhancement from ‘A-‘ in 2024 and ‘B’ in 2023 for climate, and ‘C’ for water. This progress reflects Lupin’s dedication to continuous improvement and its efforts to establish new sustainability standards.

The company’s Executive Director, Ramesh Swaminathan, attributed this achievement to Lupin’s innovative approaches, collaborative efforts, and transparency. He emphasized that the CDP’s framework has helped shape and accelerate the company’s climate initiatives, driving ongoing progress. Lupin’s commitment to sustainability is also reflected in its S&P Global ESG score of 91 in 2025, which is a best-in-class global achievement. This score positions Lupin among a select group of companies worldwide that have surpassed the 90-point threshold, demonstrating its exceptional performance in environmental, social, and governance (ESG) aspects.

Lupin’s achievement is a significant milestone in the pharmaceutical industry, highlighting the company’s dedication to reducing its environmental impact while generating lasting value for its communities and the planet. By prioritizing sustainability and transparency, Lupin is setting a high standard for the industry and demonstrating its commitment to creating a better future for all stakeholders. Overall, Lupin’s double ‘A’ rating from CDP and its exceptional ESG score are a testament to the company’s leadership in sustainability and its efforts to make a positive impact on the environment.

Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest ‘A’ leadership rating from the Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. This recognition solidifies Lupin’s position as a global leader in championing sustainability and transparency. The company’s double ‘A’ rating in Climate and Water is a testament to its commitment to mitigating climate risks, reducing carbon emissions, and ensuring responsible water management throughout its operations.

This achievement represents a substantial improvement from Lupin’s previous ratings, with the company moving from ‘A-‘ in 2024 to ‘A’ in 2025, and from ‘B’ in 2023 to ‘A’ in 2025 for climate and water, respectively. This significant year-over-year progress demonstrates Lupin’s dedication to sustainability and its proactive initiatives aimed at reducing its environmental impact.

Ramesh Swaminathan, Executive Director, Global CFO and Head of API Plus SBU at Lupin, expressed pride in the company’s achievement, stating that Lupin has advanced its efforts to reduce environmental impact through innovation, collaboration, and transparency. He also acknowledged the role of CDP’s strict framework in shaping and accelerating the company’s climate initiatives, fostering ongoing progress.

In addition to the CDP rating, Lupin has also achieved an S&P Global ESG score of 91 in 2025, a best-in-class global achievement that positions the company among a distinguished group of companies worldwide that have surpassed the 90-point threshold. This recognition demonstrates Lupin’s commitment to establishing new sustainability standards and generating lasting value for its communities and the planet. Overall, Lupin’s achievements in sustainability and environmental responsibility underscore its position as a responsible and forward-thinking global pharmaceutical leader.